220 related articles for article (PubMed ID: 25385802)
21. Adenoid cystic carcinoma of lacrimal gland.
Ohnishi Y; Abe M; Shimokawa S; Hara Y; Ishibashi T; Fukui M; Jingu K
Jpn J Ophthalmol; 1983; 27(1):96-101. PubMed ID: 6304387
[TBL] [Abstract][Full Text] [Related]
22. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
[TBL] [Abstract][Full Text] [Related]
23. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland.
Lee DA; Campbell RJ; Waller RR; Ilstrup DM
Ophthalmology; 1985 Jan; 92(1):128-34. PubMed ID: 2983279
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.
Esmaeli B; Ahmadi MA; Youssef A; Diba R; Amato M; Myers JN; Kies M; El-Naggar A
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):22-6. PubMed ID: 14752305
[TBL] [Abstract][Full Text] [Related]
25. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
26. [Primary culture and morphological characteristics of human lacrimal adenoid cystic carcinoma cells].
Zhou BQ; He YJ; Lin TT; Zhu LM
Zhonghua Yan Ke Za Zhi; 2013 Oct; 49(10):902-8. PubMed ID: 24433692
[TBL] [Abstract][Full Text] [Related]
27. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
[TBL] [Abstract][Full Text] [Related]
30. [Primary epithelial lacrimal gland tumors: the pathologic classification of 272 cases].
Ni C
Yan Ke Xue Bao; 1994 Dec; 10(4):201-5. PubMed ID: 7774690
[TBL] [Abstract][Full Text] [Related]
31. Cranio-orbital Resection Does Not Appear to Improve Survival of Patients With Lacrimal Gland Carcinoma.
Rose GE; Gore SK; Plowman NP
Ophthalmic Plast Reconstr Surg; 2019; 35(1):77-84. PubMed ID: 30130333
[TBL] [Abstract][Full Text] [Related]
32. Epithelial lacrimal gland tumors: pathologic classification and current understanding.
Weis E; Rootman J; Joly TJ; Berean KW; Al-Katan HM; Pasternak S; Bonavolontà G; Strianese D; Saeed P; Feldman KA; Vangveeravong S; Lapointe JS; White VA
Arch Ophthalmol; 2009 Aug; 127(8):1016-28. PubMed ID: 19667339
[TBL] [Abstract][Full Text] [Related]
33. Determinants of survival in parotid gland carcinoma: a population-based study.
Bhattacharyya N; Fried MP
Am J Otolaryngol; 2005; 26(1):39-44. PubMed ID: 15635580
[TBL] [Abstract][Full Text] [Related]
34. Orbitocranial approach for treatment of adenoid cystic carcinoma of the lacrimal gland.
Wilson KF; Ward PD; Spector ME; Marentette LJ
Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):397-400. PubMed ID: 21774448
[TBL] [Abstract][Full Text] [Related]
35. A survey of the histopathology of lacrimal gland lesions in a tertiary referral centre.
Teo L; Seah LL; Choo CT; Chee SP; Chee E; Looi A
Orbit; 2013 Feb; 32(1):1-7. PubMed ID: 23387446
[TBL] [Abstract][Full Text] [Related]
36. Adenoid cystic carcinoma of the lacrimal gland in a child.
Dagher G; Anderson RL; Ossoinig KC; Baker JD
Arch Ophthalmol; 1980 Jun; 98(6):1098-1100. PubMed ID: 6248005
[TBL] [Abstract][Full Text] [Related]
37. [Safety of the preoperative evaluation of pleomorphic adenoma: a retrospective analysis].
Bertelmann E; Minko N
Klin Monbl Augenheilkd; 2012 Mar; 229(3):231-5. PubMed ID: 22189826
[TBL] [Abstract][Full Text] [Related]
38. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases.
Font RL; Smith SL; Bryan RG
Arch Ophthalmol; 1998 May; 116(5):613-6. PubMed ID: 9596497
[TBL] [Abstract][Full Text] [Related]
39. Primary ductal adenocarcinoma of the lacrimal gland.
Milman T; Shields JA; Husson M; Marr BP; Shields CL; Eagle RC
Ophthalmology; 2005 Nov; 112(11):2048-51. PubMed ID: 16271319
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical features of lacrimal gland epithelial tumors.
Mendoza PR; Jakobiec FA; Krane JF
Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
